Total Payments
$2,859
2022 Payments
$217.66
Companies
23
Transactions
154
Medicare Patients
823
Medicare Billing
$87,899
Payment Breakdown by Category
Food & Beverage$2,851 (99.7%)
Education$7.70 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,851 | 153 | 99.7% |
| Education | $7.70 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $810.24 | 49 | $0 (2020) |
| PFIZER INC. | $343.73 | 28 | $0 (2021) |
| Allergan, Inc. | $272.50 | 13 | $0 (2020) |
| QOL Medical, LLC | $175.55 | 6 | $0 (2021) |
| UCB, Inc. | $166.72 | 10 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $138.46 | 11 | $0 (2020) |
| Ambu Inc. | $133.93 | 1 | $0 (2021) |
| Cook Medical LLC | $131.45 | 2 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $110.91 | 2 | $0 (2022) |
| Janssen Biotech, Inc. | $100.64 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $217.66 | 3 | STERIS CORPORATION ($81.88) |
| 2021 | $358.90 | 7 | Ambu Inc. ($133.93) |
| 2020 | $175.55 | 11 | AbbVie Inc. ($67.72) |
| 2019 | $1,142 | 76 | AbbVie, Inc. ($313.09) |
| 2018 | $754.53 | 42 | AbbVie, Inc. ($314.95) |
| 2017 | $210.03 | 15 | AbbVie, Inc. ($114.48) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2022 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $77.06 | General |
| Category: Immunology | ||||||
| 10/26/2022 | Cook Medical LLC | HEMOSPRAY (Device) | Food and Beverage | Cash or cash equivalent | $58.72 | General |
| Category: Endoscopy | ||||||
| 06/22/2022 | STERIS CORPORATION | NA (Device), Padlock Clip, Infinity | Food and Beverage | In-kind items and services | $81.88 | General |
| Category: Gastroenterology | ||||||
| 12/03/2021 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/07/2021 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/17/2021 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/11/2021 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/24/2021 | Cook Medical LLC | Hemospray (Device) | Food and Beverage | Cash or cash equivalent | $72.73 | General |
| Category: Endoscopy | ||||||
| 01/22/2021 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $133.93 | General |
| 01/14/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | In-kind items and services | $99.27 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/10/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $17.31 | General |
| 03/10/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/06/2020 | Merck Sharp & Dohme Corporation | RENFLEXIS (Biological) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/18/2020 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Immunology | ||||||
| 01/31/2020 | RedHill Biopharma Inc. | Aemcolo (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Antibiotic | ||||||
| 01/29/2020 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/27/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: IMMUNOLOGY | ||||||
| 01/15/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: IMMUNOLOGY | ||||||
| 01/14/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 01/14/2020 | Allergan, Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/24/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/23/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/20/2019 | PFIZER INC. | XELJANZ (Drug), INFLECTRA | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/19/2019 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $15.40 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 153 | 153 | $91,460 | $18,798 |
| 2022 | 4 | 201 | 205 | $124,576 | $23,005 |
| 2021 | 6 | 241 | 241 | $126,343 | $26,827 |
| 2020 | 7 | 228 | 236 | $108,011 | $19,268 |
Total Patients
823
Total Services
835
Medicare Billing
$87,899
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 46 | 46 | $42,590 | $8,760 | 20.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $25,036 | $5,370 | 21.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 61 | 61 | $23,834 | $4,668 | 19.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 53 | 53 | $47,938 | $10,077 | 21.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 75 | 75 | $45,107 | $7,610 | 16.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 62 | 66 | $29,029 | $5,015 | 17.3% |
| 43450 | Dilation of esophagus | Facility | 2022 | 11 | 11 | $2,502 | $303.23 | 12.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 76 | 76 | $41,132 | $8,593 | 20.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 39 | 39 | $36,111 | $7,291 | 20.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 72 | 72 | $28,170 | $5,643 | 20.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 20 | 20 | $14,212 | $3,457 | 24.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 13 | 13 | $2,446 | $1,208 | 49.4% |
| 43450 | Dilation of esophagus unguided | Facility | 2021 | 21 | 21 | $4,272 | $635.46 | 14.9% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 53 | 53 | $44,812 | $5,337 | 11.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 25 | 25 | $23,682 | $5,102 | 21.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 37 | 38 | $23,752 | $3,170 | 13.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 56 | 56 | $5,600 | $1,823 | 32.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $3,025 | $1,577 | 52.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 33 | 35 | $5,250 | $1,249 | 23.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 18 | $1,890 | $1,010 | 53.4% |
About Dr. Emil Miskovsky, MD
Dr. Emil Miskovsky, MD is a Gastroenterology healthcare provider based in Lewiston, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427043942.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emil Miskovsky, MD has received a total of $2,859 in payments from pharmaceutical and medical device companies, with $217.66 received in 2022. These payments were reported across 154 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,851).
As a Medicare-enrolled provider, Miskovsky has provided services to 823 Medicare beneficiaries, totaling 835 services with total Medicare billing of $87,899. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Lewiston, ME
- Active Since 09/12/2005
- Last Updated 01/23/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1427043942
Products in Payments
- Humira (Biological) $426.18
- XELJANZ (Drug) $343.73
- STELARA (Biological) $211.55
- Cimzia (Drug) $166.72
- Creon (Drug) $161.23
- ZENPEP (Drug) $149.23
- Entyvio (Biological) $122.83
- SUCRAID (Drug) $99.27
- LINZESS (Drug) $92.71
- NA (Device) $81.88
- Sucraid (Drug) $76.28
- Hemospray (Device) $72.73
- HEMOSPRAY (Device) $58.72
- DIFICID (Drug) $58.68
- XIFAXAN (Drug) $45.54
- HUMIRA (Biological) $35.41
- MOTOFEN (Drug) $33.74
- ELEVIEW (Device) $31.92
- VIBERZI (Drug) $30.56
- Amitiza (Drug) $28.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lewiston
Dr. Oswaldo Bisbal, Md, MD
Gastroenterology — Payments: $3,688
Gastroenterology $3,688
Dr. Benjamin Stein, M.d.,, M.D.,
Gastroenterology — Payments: $3,409
Gastroenterology $3,409
Dr. Winoah Henry, M.d, M.D
Gastroenterology — Payments: $1,659
Gastroenterology $1,659
Catherine Mccrann, Md, MD
Gastroenterology — Payments: $910.59
Gastroenterology $910.59
Dr. Mark Branda, Md, MD
Gastroenterology — Payments: $559.13
Gastroenterology $559.13
Lee Hixson, M.d, M.D
Gastroenterology — Payments: $314.22
Gastroenterology $314.22